Buy or sell BioClinica stock pre IPO via an EquityZen fund
BioClinica provides integrated, technology-enhanced clinical trial management solutions.
About BioClinica Stock
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. BioClinica services maximize efficiency and manageability throughout all phases of the clinical trial process. With more than 20 years of experience and over 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia.
Executive Vice President of Corporate Development & Strategy
Executive Vice President & Chief Financial Officer
Chief Executive Officer
Executive Vice President & President of Medical Imaging & Cardiac Safety
David S Herron
Executive Vice President & President of Clinical Research
President of eHealth Solutions
Executive Vice President of Human Resources
Chief Science Officer
Chief Operating Officer